Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)

AI Briefing

• – Eli Lilly downgraded to Hold due to cooling growth
• – Valuation remains rich despite downgrade
• – Novo Nordisk price pressure increases